Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 6/20 | 0.45 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.36 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11391538 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL11389428 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL16227673 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL11389471 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL8214323 | 1.00 | LGALS8 (0.45) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL23026283 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL7919319 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL4606854 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL15353147 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB | |
| SCHEMBL7927733 | 0.94 | LGALS8 (0.46) | LGALS8OGASLC2A1MAPK1PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118236391-A | Nucleic acid, composition containing nucleic acid, conjugate, preparation method and application | 苏州瑞博生物技术股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116474107-A | Conjugate, intermediate compound thereof and application | 成都先导药物开发股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116375774-A | Conjugate, preparation method and application thereof | 苏州瑞博生物技术股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-119913147-A | Compositions and methods for modulating apolipoprotein C-III expression | IONIS制药公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119331036-A | Tri-cluster galactose compound, conjugate, preparation method and application thereof | 广州市锐博生物科技有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-110079524-B | Compositions and methods for modulating HBV and TTR expression | IONIS制药公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-111377984-B | Compounds and conjugates, methods of making and uses thereof | 苏州瑞博生物技术股份有限公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-112876534-B | Liver targeting compounds and conjugates | 苏州瑞博生物技术股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-113891892-B | Compounds and drug conjugates, methods of preparation and uses thereof | 苏州瑞博生物技术股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-111377985-B | Compounds and conjugates, methods of making and uses thereof | 苏州瑞博生物技术股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-115996755-A | Bifunctional molecules and methods of use thereof | 旗舰创业创新VI有限责任公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-2782990-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | Nonomura, Arthur M. (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013078106-A1 | METHODS AND SYSTEMS FOR GROWING PLANTS USING SILICATE-BASED SUBSTRATES, CULTIVATION OF ENHANCED PHOTOSYNTHETIC PRODUCTIVITY AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES FOR ENDOGENOUS GLYCOPYRANOSYL-PROTEIN DERIVATIVES, AND FORMULATIONS, PROCESSES AND SYSTEMS FOR THE SAME | NONOMURA ARTHUR M (US) | 2013-05-30 | — | — | WO | disclosed |